cetylpyridinium chloride anhydrous has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulati, S; Jakola, AS; Solheim, O; Unsgård, G; Weber, C | 1 |
| HEROLD, G | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Glioblastoma
| Article | Year |
|---|---|
Postoperative deterioration in health related quality of life as predictor for survival in patients with glioblastoma: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Glioblastoma; Health; Humans; Middle Aged; Multivariate Analysis; Postoperative Period; Proportional Hazards Models; Prospective Studies; Quality of Life; Treatment Outcome | 2011 |
[On the insurance law evaluation of glioblastoma multiforme].
Topics: Glioblastoma; Health; Humans; Insurance; Insurance, Health; Jurisprudence | 1963 |